APP and Alzheimer disease: In AD models, the overexpression of Sirt1 modulates the processing of APP by increasing the activity of α-secretase (Bonda et al., 2011), which shifts APP processing toward the non-amyloidogenic Aβ forms (Bonda et al., 2011).